In the current work, we examine the role of FOXM1 in promoting breast cancer cell survival and aggressiveness, and we provide information delineating how these FOXM1 inhibitors suppress FOXM1 activities in cells sensitive to them. This evidence concerns the gene FOXM1 and breast carcinoma.